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Abstract 
By employing the sensitivity of single molecule fluorescent in situ hybridisation (smFISH) 
we have precisely quantified the levels and defined the temporal and spatial distribution of 
Hedgehog signalling activity during embryonic skin development, and uncovered that there is 
a Hedgehog signalling gradient along the proximal-distal axis of developing hair follicles. In 
order to explore the contribution of Hedgehog receptors Ptch1 and Ptch2 in establishing the 
epidermal signalling gradient, we quantitated the level of pathway activity generated in Ptch1 
and Ptch1;Ptch2-deficient skin and defined the contribution of each receptor to regulation of 
the levels of Hedgehog signalling identified in wild-type skin. Moreover, we show that both 
the cellular phenotype and level of pathway activity featured in Ptch1;Ptch2-deficient cells 
faithfully recapitulates the Peak level of endogenous Hedgehog signalling detected at the base 
of developing follicles, where the concentration of endogenous Shh is predicted to be highest. 
Taken together, these data demonstrate that both Ptch1 and Ptch2 play a crucial role in 
sensing the concentration of Hedgehog ligand and regulating the appropriate dose-dependent 
response. 
 
Introduction 
Precise temporal-spatial regulation of the Hedgehog (Hh) pathway activity is crucial to ensure 
normal development and prevent neoplastic transformation of cells in a number of diverse 
organs and tissues. Whilst the Hh pathway consists of a number of positive and negative 
regulators, the Patched (Ptch) protein receptors are perhaps the most important regulatory hub 
involved in the modulation Hh signalling. Ptch1 functions as a negative regulator of the 
pathway via two distinct processes. In the absence of Hh ligand, Ptch1 suppresses activity of 
the Smoothened (Smo) effector (Taipale et al., 2002), a process referred to as ligand-
independent antagonism (LIA) (Jeong and McMahon, 2005). Hedgehog ligands activate 
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signalling by binding to the Ptch1 receptor and inducing subsequent internalisation and 
lysosomal degradation of the Hh–Ptch complex (Incardona et al., 2000), thereby allowing 
translocation of Smo to the tip of the primary cilium where it is phosphorylated into an active 
form (Corbit et al., 2005) (Rohatgi et al., 2007). Ptch1 itself is a transcriptional target of the 
pathway, a feedback mechanism that acts to increase the amount of Ptch1 protein available to 
further bind and deplete Hh ligand from the microenvironment. This mechanism of Hh 
sequestration acts to limit the field of pathway activity and ultimately attenuate the Hh signal, 
an effect called ligand-dependent antagonism (LDA) (Jeong and McMahon, 2005). Mammals 
also possess a paralogous Ptch receptor, Ptch2 (Motoyama et al., 1998), however the role of 
Ptch2 has not been as comprehensively addressed as for Ptch1.  
 
Constitutive Hh signalling activity is a characteristic feature of the common skin cancer, basal 
cell carcinoma (BCC). Mouse models simulating pathway activation via manipulation of Shh, 
Ptch1, Smo or Gli, lead to epidermal hyperplasia and formation of lesions resembling human 
BCC (see (Kasper et al., 2012). A number of studies have been directed at dissecting the 
cellular origin of BCC, whereby Hh signalling activity has been activated in specific 
epidermal and HF stem/progenitor cell compartments. Despite these studies, the BCC-
initiating cell compartment remains controversial and consensus has been difficult to attain 
with some studies reporting BCC formation following Hh activation in a variety of HF stem 
cell compartments (Grachtchouk et al., 2011; Kasper et al., 2011; Peterson et al., 2015; Wang 
et al., 2011), and others indicating BCC potential from IFE structures (Adolphe et al., 2006; 
Grachtchouk et al., 2011; Villani et al., 2010; Wong and Reiter, 2011; Youssef et al., 2012; 
Youssef et al., 2010)  
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Aside from differences in the ascribed BCC cell of origin there is significant variation in the 
epidermal phenotypes of Hh pathway activation models, including: BCC potential, tumour 
latency and anatomical distribution of the lesions. We propose that variations in phenotype 
may reflect different amplitudes of Hh pathway activity in each model system. Previous 
studies by Dlugosz and colleagues (Grachtchouk et al., 2003) have shown that the magnitude 
of Hh signalling activity defines the tumorigenic potential of the pathway. We have 
previously shown that loss of Ptch1 activity is sufficient to induce BCC formation across all 
epidermal locations (Villani et al., 2010). Thus the level of activity generated in Ptch1-
deficient cells acts to define the tumorigenic threshold of Hh signalling in skin. In contrast, 
we have recently shown that concomitant inactivation of both Ptch1 and Ptch2 during 
epidermal development leads to loss of interfollicular epidermis (IFE), HF and sebaceous 
gland specification and differentiation (Adolphe et al., 2014). Taken together, these data 
indicate that different amplitudes of Hh signalling activity drive distinct cellular responses 
and cell fate decisions in the skin. 
 
In the developing neural tube, neuronal identity is defined by positional information generated 
by a Shh gradient. Recent methodology enabling quantification of Hh pathway transcriptional 
effectors has revealed that the amplitude of Hh signalling is critical in defining the gene 
expression profile and the ensuing cellular response (Cohen et al., 2015; Junker et al., 2014). 
To date, no Hh quantification studies have been performed in the skin, thus it remains 
unknown whether epidermal Hh signalling specifies different cell fate decisions in a manner 
akin to the neural tube. Here we utilise single molecule fluorescent in situ hybridisation 
(smFISH) to spatio-temporally quantitate Ptch1 and Gli1 mRNA transcription, as a read-out 
of Hh signalling activity and obtain precise quantification of epidermal Hh signalling in wild 
type, Ptch1-deficient and Ptch1;Ptch2-deficient skin. Consequently, we have defined both the 
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threshold of Hh pathway activity that leads to BCC formation and the amplitude of Hh 
signalling that specifies HF progenitor cells. In addition, our analyses of wild-type skin have 
identified a hitherto unrecognised proximal-distal Hh signalling gradient in developing hair 
follicles.  
 
 
Results 
 
Loss of Ptch receptor activity in the developing epidermis generates specific levels of 
Hedgehog pathway activity. 
We recently proposed that the difference in outcome between a tumorigenic Ptch1-deficient 
phenotype and the loss of epidermal specification and differentiation observed in 
Ptch1;Ptch2-deficient skin is attributable to differences in the amplitude of Hh signalling 
activity subsequently evoking distinct cellular responses(Adolphe et al., 2014). In order to 
define the amplitude of pathway activity we used single molecule fluorescent in situ 
hybridization (smFISH) to quantitate RNA transcript density of the Hh target genes Ptch1 and 
Gli1 in individual cells (Figure 1a) (Junker et al., 2014; Raj et al., 2008). Given follicular Hh 
pathway activity would confound the measurements attributable to loss of Ptch, we restricted 
our measurements to the interfollicular epidermis (IFE) region of each mouse model.  In 
E17.5 wild-type epidermis few Ptch1 (Figure 1b) and Gli1 transcripts were detected in the 
IFE [Ptch1: 90% of cells <0.10 transcripts/µm3 (Figure 1b) and mean transcript density of 
0.04/µm3 (Figure 1c); Gli1: 90% of cells <0.0125/µm3 (Figure 1b), mean transcript density of 
0.006/µm3 (Figure 1c)]. Loss of Ptch2 activity (Ptch2tm1/tm1) resulted in levels of Ptch1 and 
Gli1 indistinguishable from control epidermis (data not shown).  
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Loss of Ptch1 activity (K5Cre:Ptch1lox/lox) drives moderate transcriptional activation of 
downstream target genes (Figure 1a) with an ~3-fold activation in Ptch1 [90% of cells 
<0.275/µm3 (Figure 1b) and mean transcript density of 0.11/µm3 (Figure 1c)] and ~4-fold 
activation in Gli1 [90%: <0.05/µm3 (Figure 1b), mean: 0.022/µm3 (Figure 1c)]. Consistent 
with our initial hypothesis, concomitant ablation of both Ptch1 and Ptch2 
(K5Cre:Ptch1lox/lox;Ptch2tm1/tm1) results in a greater level of pathway activation with Ptch1 
transcriptional activity in Ptch1;Ptch2-deficient cells (Figure 1a) being ~9-fold higher than 
control epidermis and ~3-fold higher than Ptch1-deficient cells [97% of cells <0.65/um3 
(Figure 1b) and mean transcript density of 0.36/um3 (Figure 1c)]. Similarly, Gli1 transcription 
is dramatically amplified with an ~28-fold increase in transcriptional activation compared to 
that measured in wild-type IFE and ~7-fold increase over loss of Ptch1 alone [5% of cells 
express WT reference (<0.0125/µm3) and 15% expressing Ptch1-deficient reference levels 
(<0.05/µm3) (Figure 1b) and mean transcript density of 0.16/µm3 (Figure 1c)]. Overall, these 
data clearly indicate that Ptch2 plays a critical and substantial role in attenuating Hh pathway 
signalling in the absence of Ptch1 LDA and LIA. In order to address whether the amplitude of 
Hh pathway activity generated in the Ptch-deficient skin mutants model properties of 
endogenous epidermal Hh signalling activity, we set out to define the temporal and spatial 
dynamics of Hh signalling and quantitate the amplitude of Hh-responsive cell populations in 
wild-type skin. 
 
Hair follicles exhibit a proximal-distal Hedgehog signalling gradient  
In contrast to the negligible level of Ptch1 and Gli1 in E17.5 wild-type IFE (Figure 1), we 
observed a proximal-distal distribution of Ptch1 (Figure 2a) and Gli1 in developing HFs, 
highest at the proximal base and decreasing towards the IFE. Corresponding heat map 
intensity plots revealed three distinct levels of pathway activity in HFs, with clear boundaries 
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demarcating each threshold (Figure 2b). We calculated that follicular cells residing in the 
uppermost third of the HF exhibit levels of mRNA transcript densities identical to IFE basal 
cells (Figure 2b: dark blue-heat map density). Follicular cells located in the central region of 
developing HFs exhibit a moderate measure of Ptch1 transcriptional activation (ranging 
between 0.10/µm3 and 0.20/µm3) (Figure 2b: light blue-heat map density). In contrast, 
proliferating cells located at the base of the HF and actively invading the dermis, exhibit the 
greatest measure of Ptch1 transcript density (ranging between 0.20/µm3 and 0.4/µm3) (Figure 
2b: red heat map density). Numerically, the moderate amount of Gli1 and Ptch1 mRNA 
present in centrally located wild-type HF cells is directly comparable to the amplitude of 
pathway activity defined in Ptch1-deficient cells (Figure 1). Moreover, the greatest detected 
level of epidermal Hh signalling at the HF base is directly comparable to the amplitude of 
pathway activity defined in Ptch1;Ptch2-deficient cells (Figure 1).  
 
In order to define the spatio-temporal distribution of Hh signalling activity during HF 
development we quantitated the Ptch1 and Gli1 transcript density along the proximal-distal 
length of HFs at different stages of the HF cycle. Previous studies have shown that Hh 
signalling is dispensable for HF initiation and hair germ development (stage 2) (Chiang et al., 
1999; St-Jacques et al., 1998). Consistent with these findings, we observed low levels (90% 
<0.10/µm3) of Ptch1 mRNA in cells of the hair placode and hair germ (Figure 2c and d). 
Production of Shh ligand at the base of HFs as they transition between stage 2 and 3 (hair 
peg) results in an immediate and dramatic increase in Ptch1 transcript density (90% 
<0.35/µm3) (Figure 2f and g: red circle), directly comparable to the mean transcript density 
observed in Ptch1;Ptch2-deficient skin (Figure 1). As HFs proceed through each stage of 
maturation, the pool of cells located at the base of the HF continue to express the abundant 
Ptch1 transcripts (>0.20/µm3), equivalent to the amplitude of pathway activity defined in 
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Ptch1;Ptch2-deficient cells (2i and j: red circle). As the HF lengthens and cells become more 
distal to the Shh source, Hh signalling activity decreases (Figure 2g and j: blue arrow) to a 
threshold of signalling equivalent to that measured in Ptch1-deficient cells.  
 
In order to address whether the developmental Hh signalling gradient persists in late stage 
anagen as the HF continues to lengthen and cells become even more distal to the Shh source, 
we screened P10 control skin. Akin to E17.5 HFs, we observed a proximal-distal gradient of 
Ptch1 mRNA (Figure 2e) and corresponding heat map intensity plots reveal the persistence of 
three distinct levels of pathway activity (Figure 2l and m). These data show the maintenance 
of clear threshold boundaries throughout anagen growth.   
 
Since Ptch1;Ptch2-deficient cells exhibit an equivalent amplitude of Hh signalling activity as 
the cells located at the base of wild-type HFs, we set out to determine whether the phenotype 
of Ptch1;Ptch2-deficiency is replicated in the corresponding endogenous cell population. One 
characteristic feature of Ptch1;Ptch2-deficient epidermal cells is loss of keratin 5 (K5) and 
K14 expression, indicating loss of epidermal basal cell fate and acquisition of a more 
primitive progenitor-like state (Adolphe et al., 2014). Prior to Hh pathway activation all basal 
cells of E17.5 IFE and hair placode/germ exhibit K14 expression (Figure 2e). However, 
immediately upon Hh activation at the base of a hair peg, we observe a dramatic decrease in 
K14 expression (Figure 2h: red arrow). Indeed, cells during all stages of HF formation that 
express the greatest detected (Ptch1;Ptch2-deficient-like) measure of pathway activity present 
with a decrease in K14 expression (Figure 2k: red arrow). We observed a similar phenotypic 
correlation between HF cells expressing the greatest detected measure of pathway activity and 
Ptch1;Ptch2-deficiency using a number of other markers. For example, both Ptch1;Ptch2-
deficient keratinocytes and wild-type follicular cells located in the HF bulb exhibit loss of 
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cell-cell adhesion. Cells presenting with K14 downregulation (Figure 3a, c, e and g) 
concurrently exhibit decreased e-cadherin (Figure 3b and f), p120-catenin (Figure 3d and h) 
and ZO-1 (data not shown) expression. These data further support the contention that 
Ptch1;Ptch2-deficiency results in an amplitude of Hh signalling activity that is recapitulated 
during normal epidermal development.  
 
 
Discussion 
 
The smFISH data described here have defined the spatio-temporal domains of Hh expression 
and defined the amplitudes of Hh activity in both wild-type and Ptch mutant epidermis. These 
data indicate that both Ptch1 and Ptch2 play an important role in sensing and establishing a 
previously unappreciated Hh signalling gradient in the skin. 
 
Both Ptch1 and Ptch2 play an essential role in sensing and transducing the epidermal 
Hedgehog morphogen gradient 
Our smFISH analyses have identified graded levels of Hh pathway activity emanating along 
the proximal-distal axis of developing HFs (Figure 4a). We did not observe a spike in Hh 
pathway activity along the HF structure of embryonic HFs. Hence, it is likely that the nerve 
fiber located at the upper bulge region, as described by (Brownell et al., 2011), becomes a 
source of Hh ligand only in post-natal HF structures and is not a developmental source of Hh 
ligand. Here we show that keratinocytes located most distal from the Shh source, namely the 
IFE basal cell compartment and follicular cells located above the future HF bulge, exhibit an 
endogenously low Basal level of Ptch1 and Gli1 transcriptional activity (Figure 4a: dark blue 
colour scheme), likely due to a nominal concentration of ligand reaching this target field. In 
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contrast, follicular cells located between the future HF bulge and HF bulb exhibit elevated 
levels of Ptch1 and Gli1 transcriptional activity (Figure 4a: light blue colour scheme), 
consistent with their more proximal location to the Shh source and thus exposure to an 
intermediate concentration of ligand. Interestingly, the quantitated level of signalling activity 
within these centrally located HF cells is equivalent to the level of Hh activity  measured in 
Ptch1-deficient cells. Given that in vitro studies have suggested Hh ligands display equivalent 
binding affinity to both Ptch1 and Ptch2 (Carpenter et al., 1998), it is plausible that the 
magnitude of signalling activity in this wild-type HF location is generated by a ligand 
concentration that bind a proportion of available Ptch1 and Ptch2 receptors, resulting in loss 
of LIA and subsequent activation of the Smo effector. However, Ptch1-heterozygous;Ptch2-
homozygous-deficient skin does not exhibit tumorigenic activity, clearly demonstrating that a 
half dose (single functioning allele) of Ptch1-LIA is sufficient to inhibit Smo activation. Thus 
it appears saturation of a majority of Ptch1 receptors is necessary to cross the Basal threshold 
and achieve physiological activation of the Hh pathway in wild-type skin.  
 
We have also identified that the highest magnitude of Hh signalling activity established 
during epidermal development occurs in a small population of cells located at the base of 
wild-type developing HFs, in a structure referred to as the HF bulb (Figure 4a: red colour 
scheme). Given Ptch1;Ptch2-deficient keratinocytes exhibit an amplitude of pathway activity 
identical to cells of the HF bulb, it is likely that a concentration of ligand sufficiently high to 
saturate and internalize all available Ptch receptors is restricted to cells located within this 
target field (Figure 4a: RHS schematic). Taken together, these data indicate concomitant 
ablation of Ptch1 and Ptch2 is a genetic approach that mimics the biological program induced 
by the highest concentration of Shh in developing wild-type HFs (Figure 4c) and is a starting 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 11
point to ultimately dissect the molecular mechanisms involved in specification of this small 
endogenous population of progenitor-like cells.  
 
Ptch1 and Ptch2 act synergistically to repress hedgehog pathway activity  
We have previously shown that loss of Ptch1 alone is necessary and sufficient to induce basal 
cell carcinoma (BCC) formation (Adolphe et al., 2006; Villani et al., 2010). Here we have 
quantitated the level of Hh pathway activity generated in the IFE of Ptch1-deficient cells 
(K5Cre:Ptch1lox/lox), and thus defined the tumour suppressor activity threshold of the Hh 
signalling pathway (Figure 4b: light blue dotted line). Several lines of evidence have 
indicated that BCC potential is only achieved upon what has been previously described as 
high (not intermediate or low) magnitudes of Hh signalling (Grachtchouk et al., 2003), hence 
we term Ptch1-deficient cells as exhibiting a High level of Hh pathway activity (Figure 4: 
light blue colour scheme). In contrast, Ptch1;Ptch2-deficiency appears to simulate cells that 
are spatially located in the region of the HF bulb comprising multi-potent matrix progenitor 
cells. By calculating the threshold of transcriptional activity produced in Ptch1;Ptch2-
deficient cells (K5Cre:Ptch1lox/lox;Ptch2tm1/tm1) we have identified the level of Hh pathway 
signalling active in this pool of progenitor cells (Figure 4c: red dotted line). Genetic ablation 
of Ptch1 and Ptch2 results in ligand-independent, constitutive pathway activation downstream 
of Ptch repression (LIA). Complete de-repression of the pathway as modelled in Ptch1;Ptch2-
deficient cells thus likely represents maximal Hh target gene transcription, which we define as 
a Peak level of signalling activity (Figure 4, red colour scheme).  
 
It is predicted that Ptch1;Ptch2-deficient epidermis is not sensitive to Shh. Given Ptch1 and 
Ptch2 have been ablated, there is no means for a cell to detect, bind and interpret the presence 
of Shh ligand. However, in order to exclude the possibility that expansion of Shh ligand was 
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attributable to persistent Peak pathway activity throughout Ptch1;Ptch2-deficient epidermis, 
we screened for the distribution of Shh. Interestingly, Shh was not detectable by smFISH in 
Ptch1;Ptch2-deficient epidermis (Supplementary Figure 1). Given that all cells in 
Ptch1;Ptch2-deficient epidermis are genetically identical, it appears that Shh producing cells 
are not specified in response to Peak signaling activity.  Moreover, it is important to note that 
we observed the histological phenotype of Ptch1;Ptch2;Smo-deficient epidermis is 
indistinguishable from that of Smo-deficient epidermis (Supplementary Figure 2), indicating 
Peak signalling is transduced via the canonical (Smo-dependent) pathway.  
 
Peak signalling activity exhibits an approximate 3-fold (Ptch1) and 7-fold (Gli1) increase in 
transcript density when compared to High signalling activity. Given loss of Ptch2 alone does 
not activate Ptch1 or Gli1 transcriptional activity, a substantial synergy exists between Ptch1 
LDA/LIA and Ptch2 LDA/LIA in governing Hh pathway repression in the skin. The 
phenotype of complete pathway de-repression (Ptch1;Ptch2-deficiency) and whether Ptch 
synergism exists in other developmental systems remains to be determined. Recent reports 
describe the effects of Ptch1;Ptch2 LDA ablation in the neural tube (Holtz et al., 2013). 
However, these studies were performed in the presence of an MT-Ptch1 transgene that 
ubiquitously expresses low levels of Ptch-LIA (Milenkovic et al., 1999), and is therefore not 
representative of ligand-independent, constitutive pathway de-repression as described here.  
 
Consistent with Ptch1 playing an important role in sequestering Hh and limiting the diffusion 
of the ligand along a field of cells, we show that Ptch1-deficiency leads to an increased target 
field of Peak signalling towards the location of the HF bulge, culminating in a distal 
expansion of HF progenitor-like cells (Figure 4b). Ptch1-LIA is therefore crucial in 
preventing pathway tumorigenicity and Ptch1-LDA essential to restrict Hh signalling and 
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ensure appropriate proximal-distal HF cell fates. Similarly, we have identified Ptch2 plays a 
vital role in establishing the epidermal Shh morphogen gradient and generating the Hh 
transcriptional code operating in actively growing HF progenitor cells.  
 
Overall, our data suggest the availability of Ptch at the cell surface plays a critical role in 
regulating epidermal lineage specification, differentiation and proliferation by sensing the Shh 
morphogen gradient and defining whether a Basal, High or Peak transcriptional code is 
generated. The downstream targets specifying neoplastic transformation (High) or HF 
progenitor cell fate (Peak), and which ultimately define the boundaries between each 
epidermal gradient threshold remain to be determined. Although we postulate that the positive 
and negative regulators of Hh ligand upstream of Ptch (namely Cdo, Boc and Hhip) are 
unlikely to contribute or enhance the level of epidermal signaling following Ptch1;Ptch2 
ablation, further studies are warranted to identify whether they play a role in regulating the 
spatial distribution of transcription factors and demarcating the three distinct epidermal 
signaling thresholds defined here. However, it is clear that distinct levels of Hh signalling are 
associated with diverse biological responses. Thus dissecting the role of Hh pathway activity 
in normal organogenesis and disease requires a careful and quantitative consideration of 
pathway activity at the level of the individual cell. 
 
 
Materials and Methods 
 
K5Cre, Ptch1 and Ptch2 mice have been previously described (Adolphe et al., 2014) and 
experiments performed according to the University of Queensland animal ethics guidelines. 
E18.5 flank skin samples were fixed in 4% PFA for 1 hour at 4°C, and incubated overnight in 
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30% sucrose at 4°C before embedding in OCT compound. Tissue blocks were sectioned at 
8µm, postfixed in 4% PFA at room temperature for 15 minutes, rinsed in PBS and incubated 
overnight in 70% ethanol at 4°C. All experiments were performed in technical and biological 
replicates. 
For each mRNA examined a set of 20-mer DNA oligonucleotides complementary to the 
coding region of the gene of interest were designed using an online program 
(http://www.biosearchtech.com/stellarisdesigner/) and synthesized with 3’-amino 
modifications by Biosearch Technologies. Probes were coupled to Alexa594 and Cy5 
fluorophores as previously described (Lyubimova et al., 2013). Tissue sections were 
hybridized as previously described (Lyubimova et al., 2013; Raj et al., 2008). Briefly, 
sections were hybridized with ~0.3 ng/µl of labelled probe sets for each mRNA overnight at 
30°C in the dark. Sections were washed twice for 30 minutes and then mounted in anti-bleach 
buffer. Images were acquired on a Perking-Elmer Spinning Disc confocal microscope with a 
100x oil-immersion objective (numerical aperture 1.4) using Perking Elmer Volocity 
software. Images were recorded as stacks with a z spacing of 0.3µm. Representative raw data 
images are shown in Figure 1a.  
Diffraction-limited dots corresponding to single mRNA molecules were detected in 3D by 
custom Matlab software using previously described algorithms (Raj et al., 2008). Briefly, the 
images were first filtered using a three-dimensional Laplacian of Gaussian filter with a width 
of 15 pixels and a standard deviation of 1.5 pixels. We then chose the intensity threshold at 
which the number of connected components was least sensitive to the threshold (Itzkovitz et 
al., 2012). Individual images (tiles) were taken and stitched together in Matlab software (Raj 
et al., 2008) using stage coordinates and cross-correlation analysis. Transcript density (units: 
#/µm3) was measured in pseudo cells of 5 µm x 5 µm size to generate 2D heat map plots. 
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Representative tiled data images are shown in Supplementary Figure 3. 1D transcript density 
traces were generated by plotting the mean value in sliding windows along the posterior-distal 
axis of a developing HF. Colored patches designate the standard deviation across pseudo 
cells. 
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Figure Legends 
 
Figure 1: Quantitation of Hedgehog pathway activity in wild-type and Patched-deficient 
basal cells epidermis a) Maximum z projections (thickness 1.5µm) of smFISH raw data in 
control and Ptch1;Ptch2-deficient keratinocytes. Dapi nuclear stain shown in blue. Scale bar 
5µm.  b) Detected transcripts and corresponding heat maps showing abundance of Ptch1 
mRNA in E17.5 control, Ptch1-deficient and Ptch1;Ptch2-deficient epidermis. Analyses were 
restricted to the interfollicular basal cell compartment (yellow dotted regions).  Scale bar 
50µm.  c) Quantitation of Ptch1 and Gli1 transcript density distribution and d) Mean 
transcript levels in E17.5 control (red), Ptch1-deficient (blue) and Ptch1;Ptch2-deficient 
(green) cells. * lower signal attributable to a fold in the IFE, hence reduced cell density 
available for calculation. 
 
Figure 2: Hedgehog pathway activity in embryonic hair follicles. a) Detected transcripts 
and  b) corresponding heat map showing the spatial abundance of Ptch1 mRNA along the 
posterior-distal axis of aE17.5 developing HF.  Note: three detectable levels of Hh pathway 
activity in embryonic HFs.  c) Low levels of Ptch1 transcription are detected in early stage 
hair germs. d) Mean transcript density as a function of HF length. Shaded area corresponds to 
standard deviation. e) K14 is expressed in all keratinocytes of the hair germ.  f) The Hh 
pathway becomes active in a stage 3 HF, with g) abundant Ptch1 transcripts (>0.20 transcript 
density/µm3) occurring in the proximal keratinocytes of the hair peg (red circle), concomitant 
with  h) loss of K14 protein expression (red arrow). i and j) Abundantly Hh-responsive cells 
remain localised to the proximal tip (red circle) of further developed (Stage 5) HFs.  k) Loss 
of K14 protein observed in cells exhibiting abundant Ptch1 transcripts (>0.20 transcript 
density/µm3) (red arrow). l) Detected transcripts and m) corresponding heat map showing the 
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spatial abundance of Ptch1 mRNA along the posterior-distal axis of a late stage anagen (P10) 
HF. Note: three detectable levels of Hh pathway activity in P10 HFs.  Scale bar  50 µm. IFE: 
interfollicular epidermis, HF: hair follicle, K14: keratin 14 
 
Figure 3: Parallel protein expression profile in proximal HF and Ptch1;Ptch2-deficient 
cells.  Concomitant loss of a) K14 and b) e-cadherin in E18.5 developing HFs (arrows). 
Concomitant loss of c) K14 and d) p120-catenin in E16.5 developing HFs (arrows). 
Concomitant loss of e) K14 and f) e-cadherin in E18.5 Ptch1;Ptch2-deficient keratinocytes 
(asterisk). Concomitant loss of g) K14 and h) p120-catenin in E18.5 Ptch1;Ptch2-deficient 
keratinocytes (asterisk). Scale bar  50 µm. 
 
Figure 4: Model for the regulation of epidermal morphogen signalling via Patched 
activity. a) Diagrammatic representation of the Hedgehog signalling gradient present in 
developing HFs. Three distinct levels of hedgehog signalling (indicated by colour), illustrated 
here as abundance of Gli1 transcript. Middle panel: correlation between level of pathway 
activity and cell fate specification along the proximal-distal axis of the HF. RHS panel: 
proposed model of Ptch receptor saturation along the HF gradient. b) Loss of Ptch1 receptor 
activity results in distal expansion of High land Peak levels of Hh activity. Blue dotted line: 
denotes threshold attributable to tumour formation. Loss of Ptch1-LDA results in decreased 
ligand sequestration leading to an increased range of ligand diffusion, thereby affecting the 
demarcation of standard threshold boundaries. c) Ptch1 and Ptch2 receptor saturation results 
in cell autonomous, constitutive Peak activity. Scale bar  50 µm. 
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